Sinovac to Present at the Susquehanna Financial Group's Second Annual Beijing Management Summit Conference

  • Author: 佚名
  • Date: 2008-09-02
  • Source: 本站原创
  • Pageview: 7958

Sinovac to Present at the Susquehanna Financial Group's Second Annual Beijing Management Summit Conference
Monday September 1, 8:00 am ET

BEIJING, Sept. 1 /Xinhua-PRNewswire/ -- Sinovac Biotech Ltd. (Amex: SVA - News), a vaccine-focused biotech company in China, announced today that Mr. Weidong Yin, Chairman, President and CEO, is scheduled to present at the Susquehanna Financial Group's Second Annual Beijing Management Summit Conference, at Grant Hyatt Beijing Hotel in Beijing, China. Sinovac's presentation is scheduled for Thursday, September 11th at 1:35 p.m.

About Sinovac

Sinovac Biotech Ltd. is a China-based biopharmaceutical company that focuses on the research, development, manufacture and commercialization of vaccines that protect against human infectious diseases. Sinovac's commercialized vaccines include Healive® (hepatitis A), Bilive® (combined hepatitis A and B), Anflu® (influenza) and Panflu(TM) (H5N1). Sinovac is currently developing Universal Pandemic Influenza vaccine and Japanese encephalitis vaccine. Additional information about Sinovac is available on its website, http://www.sinovac.com . To be added to our distribution list, please email: info@sinovac.com.

Safe Harbor Statement

This announcement contains forward-looking statements. These statements are made under the "safe harbor" provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by words or phrases such as "will," "expects," "anticipates," "future," "intends," "plans," "believes," "estimates" and similar statements. Among other things, the business outlook and quotations from management in this press release contain forward-looking statements. Statements that are not historical facts, including statements about Sinovac's beliefs and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties. A number of important factors could cause actual results to differ materially from those contained in any forward- looking statement. Sinovac does not undertake any obligation to update any forward-looking statement, except as required under applicable law.

    For more information, please contact:
Contact Information:
Helen G. Yang
Sinovac Biotech Ltd.
Tel:   +86-10-8289-9871
Fax:   +86-10-6296-6910
Email: info@sinovac.com
    Investors:
Stephanie Carrington
The Ruth Group
Tel:   +1-646-536-7017
Email: scarrington@theruthgroup.com
    Media:
Janine McCargo
The Ruth Group
Tel:   +1-646-536-7033
Email: jmccargo@theruthgroup.com
Bookmark and Share

Copyright © 2001-2015 Sinovac Biotech Ltd. All Rights Reserved.

Add: No. 39 Shangdi Xi Road, Haidian District, Beijing, P.R.C. 100085 Supported by elongtian